Leap Therapeutics Newsroom

Leap Therapeutics Analyst Ratings

BenzingaNov 15 20:30

H.C. Wainwright Maintains Leap Therapeutics(LPTX.US) With Buy Rating, Maintains Target Price $5.5

Futu NewsNov 15 19:34

Baird Maintains Leap Therapeutics(LPTX.US) With Buy Rating, Maintains Target Price $9

Futu NewsAug 13 22:31

Leap Therapeutics Price Target Maintained With a $5.50/Share by HC Wainwright & Co.

Dow JonesAug 13 19:20

Leap Therapeutics Analyst Ratings

BenzingaAug 13 19:13

H.C. Wainwright Maintains Leap Therapeutics(LPTX.US) With Buy Rating, Maintains Target Price $5.5

Futu NewsAug 13 18:31

Maintained Buy Rating for Leap Therapeutics Amid Promising Clinical and Financial Outlook

TipRanksAug 13 18:26

Leap Therapeutics: Runway To Fund Operating, Capital Spending Into 2Q 2026 >LPTX

Dow JonesAug 12 19:06

Leap Therapeutics Analyst Ratings

BenzingaJun 29 00:47

Rodman & Renshaw Initiates Coverage On Leap Therapeutics With Buy Rating, Announces Price Target of $8

BenzingaJun 29 00:47

Buy Rating Affirmed for Leap Therapeutics on Strong Trial Prospects and Solid Financials

TipRanksMay 16 16:25

HC Wainwright & Co. : Maintaining the Leap Therapeutics (LPTX.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $7.00 to $5.50.

Zhitong FinanceMay 14 19:51

Leap Therapeutics Analyst Ratings

BenzingaMay 14 19:50

HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $5.5

BenzingaMay 14 19:50

Baird Adjusts Price Target on Leap Therapeutics to $9 From $11, Maintains Outperform Rating

MT NewswiresMar 19 21:30

Baird Maintains Outperform on Leap Therapeutics, Lowers Price Target to $9

BenzingaMar 19 19:10

Leap Therapeutics Analyst Ratings

BenzingaMar 19 18:50

HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Maintains $7 Price Target

BenzingaMar 19 18:50

Leap Therapeutics: Promising Clinical Outcomes and Upcoming Catalysts Bolster Buy Rating

TipRanksMar 19 18:25

Maintaining Buy Rating on Leap Therapeutics: Promising DKN-01 Trials and Undervalued Market Potential

TipRanksJan 26 13:49